CALL US: 206.533.3854
CALL US  206.533.3854

DEFEND YOUR IP

Patent Litigation and Post-Grant Proceedings

Patent litigation is constantly evolving, with changes in how – and in what courts – competitors and non-practicing entities (NPEs) engage in offensive and defensive litigation. In the early 2020s, filings before the USPTO’s Patent Trial and Appeal Board have evened out, while high-volume NPEs seem to be leading the federal litigation charge.

AEON Law’s work to give clients a strong litigation position begins well before litigation, identifying patentable inventions and crafting solid patent claims that hold up in court and before the PTAB.

Our goal in any litigation or administrative proceeding is to get our clients to their business objectives as efficiently as possible. From the beginning, we work to identify the optimal outcome and prepare the strategy that fits the client’s goals. While we have decades of trial experience, we also help our clients resolve disputes through settlement, mediation, and arbitration.

The best strategy might include motion practice in federal court, challenging or defending a patent in PTAB Inter Partes Review or Post-Grant Review, or – often – some combination thereof. We represent a mix of plaintiffs and defendants, and our patent prosecution experience also helps us take a big-picture, business-oriented approach to litigation.

AEON Law also can offer contingent fee arrangements. This approach keeps costs predictable and strategies efficient.

During the heat of litigation, it can be difficult to keep business objectives at the forefront. AEON Law’s business-focused approach to litigation helps clients maintain a strong market position and intellectual property rights.

Let's work together.

Contact us to set up a meeting with a litigation attorney on our team.

More Ways to Defend

Related Articles

Federal Circuit Reverses Novartis Patent Decision

The Federal Circuit has issued a precedential decision reversing a lower court’s decision that certain claims of Novartis’s patent for the heart drug Entresto were ...
Read More

Second Circuit Upholds Ed Sheeran’s Win in Copyright Case

The Second Circuit has upheld a lower court’s decision that musician Ed Sheeren didn’t infringe the copyright for Marvin Gaye’s 1973 song “Let’s Get It ...
Read More

Federal Circuit Affirms Patent Non-Infringement Based on Deleted Term

The Federal Circuit has affirmed a judgement of non-infringement of a patent based on a term that appeared in a provisional patent application but was ...
Read More

Stay Informed

Sign up to receive Patent Poetry—a monthly roundup of key IP issues in our signature haiku format. Four articles (only 68 syllables); zero hassle.

SECTORS

HIGH
TECHNOLOGY

Artificial Intelligence

Blockchain & Cryptocurrency

Computer Technology & Software

Consumer Electronics

Electrical Devices

MECHANICAL
& PRODUCTS​

Cleantech

Mechanical Devices

Consumer & Retail Products

Hardware & Tools

Toys & Games

LIFE SCIENCES
& CHEMISTRY​

Biotechnology

Chemical Compounds

Digital Health

Healthcare Products

Pharmaceuticals

BRANDING
& CREATIVE​

Books & Publications

Brand Creation

Luxury Products

Photography & Video

Product Design

call us  206.533.3854